Jang KS - Search Results

1

Comprehensive analysis of differential gene expression profiles on diclofenac-induced acute mouse liver injury and recovery.

Chung H, Kim HJ, Jang KS, Kim M, Yang J, Kim JH, Lee YS, Kong G. Chung H, et al. Among authors: jang ks. Toxicol Lett. 2006 Sep 30;166(1):77-87. doi: 10.1016/j.toxlet.2006.05.016. Epub 2006 Jun 12. Toxicol Lett. 2006. PMID: 16859844

2

Comprehensive analysis of differential gene expression profiles on carbon tetrachloride-induced rat liver injury and regeneration.

Chung H, Hong DP, Jung JY, Kim HJ, Jang KS, Sheen YY, Ahn JI, Lee YS, Kong G. Chung H, et al. Among authors: jang ks. Toxicol Appl Pharmacol. 2005 Aug 1;206(1):27-42. doi: 10.1016/j.taap.2004.11.004. Epub 2004 Dec 24. Toxicol Appl Pharmacol. 2005. PMID: 15963342

3

Differential gene expression profiles in the steatosis/fibrosis model of rat liver by chronic administration of carbon tetrachloride.

Chung H, Hong DP, Kim HJ, Jang KS, Shin DM, Ahn JI, Lee YS, Kong G. Chung H, et al. Among authors: jang ks. Toxicol Appl Pharmacol. 2005 Nov 1;208(3):242-54. doi: 10.1016/j.taap.2005.03.002. Toxicol Appl Pharmacol. 2005. PMID: 16239168

4

Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.

Jang KS, Han HX, Paik SS, Brown PH, Kong G. Jang KS, et al. Cancer Lett. 2006 Dec 8;244(2):203-10. doi: 10.1016/j.canlet.2005.12.016. Epub 2006 Feb 8. Cancer Lett. 2006. PMID: 16469432

5

MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers.

Jang KS, Paik SS, Chung H, Oh YH, Kong G. Jang KS, et al. Cancer Sci. 2006 May;97(5):374-9. doi: 10.1111/j.1349-7006.2006.00186.x. Cancer Sci. 2006. PMID: 16630134 Free PMC article.

6

Comprehensive analysis of differential gene expression profiles on D-galactosamine-induced acute mouse liver injury and regeneration.

Chung H, Kim HJ, Jang KS, Kim M, Yang J, Kang KS, Kim HL, Yoon BI, Lee MO, Lee BH, Kim JH, Lee YS, Kong G. Chung H, et al. Among authors: jang ks. Toxicology. 2006 Oct 3;227(1-2):136-44. doi: 10.1016/j.tox.2006.07.026. Epub 2006 Aug 4. Toxicology. 2006. PMID: 16962228

7

Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.

Chung H, Jung YM, Shin DH, Lee JY, Oh MY, Kim HJ, Jang KS, Jeon SJ, Son KH, Kong G. Chung H, et al. Among authors: jang ks. Int J Cancer. 2008 Feb 15;122(4):816-22. doi: 10.1002/ijc.23182. Int J Cancer. 2008. PMID: 17957784

8

Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.

Lee JY, Jang KS, Shin DH, Oh MY, Kim HJ, Kim Y, Kong G. Lee JY, et al. Among authors: jang ks. Cancer Res. 2008 Jun 1;68(11):4201-9. doi: 10.1158/0008-5472.CAN-07-2570. Cancer Res. 2008. PMID: 18519679 Free article.

9

Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.

Shin DH, Park JH, Lee JY, Won HY, Jang KS, Min KW, Jang SH, Woo JK, Oh SH, Kong G. Shin DH, et al. Among authors: jang ks, jang sh. Oncotarget. 2015 Jul 10;6(19):17276-90. doi: 10.18632/oncotarget.3640. Oncotarget. 2015. PMID: 25938540 Free PMC article.

10

CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling.

Choi HJ, Jin S, Cho H, Won HY, An HW, Jeong GY, Park YU, Kim HY, Park MK, Son T, Min KW, Jang KS, Oh YH, Lee JY, Kong G. Choi HJ, et al. Among authors: jang ks. EMBO Rep. 2019 Oct 4;20(10):e48058. doi: 10.15252/embr.201948058. Epub 2019 Aug 30. EMBO Rep. 2019. PMID: 31468695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters